SCHEMBL9048281

SCHEMBL9048281

CCCCCCCCCCCCCCCCC(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@H](O)[C@@H]1O

nearest known ligand 0.65

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.65
LMNA P02545 1/20 0.59
THRB P10828 1/20 0.59
MTOR P42345 1/20 0.59
MDM2 Q00987 1/20 0.59
NCOA1 Q15788 1/20 0.59
NCOA3 Q9Y6Q9 1/20 0.59
P2RY2 P41231 3/20 0.52
TSHR P16473 1/20 0.52
GLA P06280 1/20 0.52
P2RY6 Q15077 1/20 0.49
ST6GAL1 P15907 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1403456 1.00 L3MBTL1 (0.65) L3MBTL1LMNATHRBMTORMDM2
SCHEMBL11858671 1.00 L3MBTL1 (0.65) L3MBTL1LMNATHRBMTORMDM2
SCHEMBL9047413 1.00 L3MBTL1 (0.65) L3MBTL1LMNATHRBMTORMDM2
SCHEMBL9046105 1.00 L3MBTL1 (0.65) L3MBTL1LMNATHRBMTORMDM2
SCHEMBL9046957 1.00 L3MBTL1 (0.65) L3MBTL1LMNATHRBMTORMDM2
Hydrochloric Acid SCHEMBL11852644 0.99 L3MBTL1 (0.64) L3MBTL1LMNATHRBMTORMDM2
SCHEMBL13003024 0.96 L3MBTL1 (0.64) L3MBTL1LMNATHRBMTORMDM2
Elacytarabine SCHEMBL15140172 0.95 L3MBTL1 (0.59) L3MBTL1LMNATHRBMTORMDM2
Elacytarabine SCHEMBL12137632 0.95 L3MBTL1 (0.59) L3MBTL1LMNATHRBMTORMDM2
SCHEMBL7684283 0.95 L3MBTL1 (0.59) L3MBTL1LMNATHRBMTORMDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0536936-B1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use SANKYO CO (JP) 1996-08-14 EP claimed
EP-0536936-B1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use SANKYO CO (JP) 1996-08-14 EP disclosed